NEUPOGEN 30 MU (0.3 mg/ml), solution for injection 5 bottles of 1 ml
Active ingredients: Filgrastim
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection5 bottles of 1 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NEUPOGEN 30 MU (0,3 mg/mL), solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 5 flacon(s) en verre de 1 ml
- Marketing authorisation holder
- AMGEN EUROPE
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jan 2002
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69225686CIP73498118CIP133400934981180Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FILGRASTIMsolution | 300 microgrammes (30 M.U.) · un flacon de 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.